CINCINNATI TECH

Cincinnati Biotech

Christ Hospital Launched CRISPR Cholesterol Trial

Christ Hospital Launched CRISPR Cholesterol Trial

The study evaluates a gene-editing infusion designed to provide a permanent reduction in cholesterol levels.

Live Poll

Would you trust experimental gene-editing therapies to manage your long-term health risks?